WAYNE, Pa.--(BUSINESS WIRE)--Jan. 11, 2016--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
devices for critical care and surgery, announces a new group purchasing
agreement with HealthTrust. The agreement, which became effective Dec.
1, 2015, covers Teleflex’s full line of manual ligation products,
including the Weck® Hem-o-Lok® polymer locking system, Horizon™ Titanium
Clip System, Hemoclip® Metal Clips and associated appliers.
Weck ligation products from Teleflex are designed to suit clinicians’
preferences and procedural needs.
“Since the introduction of the Weck Metal Ligating Hemoclip in 1963,
Teleflex has continued to work towards refining the science of closure
to produce metal and polymer ligation solutions for use by surgeons
around the world,” said John Tushar, president and general manager of
Teleflex Surgical. “We are pleased to have the opportunity to bring
these solutions to HealthTrust members.”
About HealthTrust
HealthTrust (legally known as Healthtrust Purchasing Group, L.P.) is
committed to strengthening provider performance and clinical excellence
through an aligned membership model and the delivery of total cost
management solutions, including supply chain solutions and a contract
and service portfolio unparalleled in quality, scope and value.
HealthTrust (www.healthtrustpg.com)
serves more than 1,400 acute care facilities and members in more than
22,300 other locations, including ambulatory surgery centers, physician
practices, long-term care and alternate care sites. Headquartered
in Brentwood, Tennessee, HealthTrust is an affiliate of Parallon
Business Solutions, LLC (www.parallon.com),
a leading provider of healthcare business and operational services,
including revenue cycle management, workforce and technology solutions.
On Twitter @healthtrustpg and @parallonconnect.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, Weck, Hem-o-lok, Hemoclip, and Horizon are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries.
© 2016 Teleflex Incorporated.
All rights reserved. MC-001916
View source version on businesswire.com: http://www.businesswire.com/news/home/20160111005053/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836